1. Management of ventricular fibrillation outside hospital;Adgey, A.A.J.; Nelson, P.G.; Scott, M.E.; Geddes, J.S.; Allen, J.D.; Zaidi, S.A.; Pantridge, J.F.;Lancet,1969
2. Reduction of sudden deaths after myocardial infarction;Ahlmark, G.; Saetre, H.; Korsgren, M.;Lancet,1974
3. The effect of KO 1173, a new anticonvulsant agent, on experimental cardiac arrhythmias;Allen, J.D.; Kofi Ekue, J.M.; Shanks, R.G.; Zaidi, S.A.;British Journal of Pharmacology,1972
4. Deaths from coronary heart disease in persons 50 years of age and younger: a community wide study;Bainton, C.R.; Peterson, D.R.;New England Journal of Medicine,1963
5. Mexiletine (KO 1173), in the management of ventricular dysrhythmias;Campbell, N.P.S.; Chaturvedi, N.C.; Kelly, J.G.; Strong, J.E.; Shanks, R.G.; Pantridge, J.F.;Lancet,1973